LINKS TO STUDIES

Stem Cell Research Articles According to the FDA, Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) are used for the treatment of acute myocardial infarction, cardiomyopathies, critical limb ischemia, bronchopulmonary dysplasia in infants, HIV infection, diabetes mellitus types I and II, both acute and chronic liver diseases, autoimmune hepatitis, cirrhosis of various etiologies, ulcerative colitis, severe aplastic anemia, Alzheimer’s disease, systemic lupus erythematosus, rheumatoid arthritis, myelodysplastic syndrome, hereditary ataxia, spinal cord injury, ankylosing spondylitis, osteoarthritis, multiple sclerosis, Duchenne muscular dystrophy, acute and resistant to steroid therapy “graft versus host” reactions, and other diseases. 


“The use of mesenchymal stem or stromal cells (MSCs) transplantation for tissue repair has received a great deal of attention in recent years, and these cells stand at the forefront of successful strategies in regenerative medicine.” Ryan, A., Murphy, M. and Barry, F. (2016)

Mesenchymal stem/stromal cell therapy, in The Biology and Therapeutic Application of Mesenchymal Cells (ed K. Atkinson), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118907474.ch29 


Superior to bone marrow stem cells (BM-MSCs), human umbilical cord blood mesenchymal stem cells (UC-MSCs) have significantly lower human leukocyte antigen expression, greater expansion capability and faster growth in vitro.” Lu Z, Zhao H, Xu J, Zhang Z, Zhang X, et al. (2013) Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Secondary Progressive Multiple Sclerosis. 

J Stem Cell Res Ther S6:002. doi:10.4172/2157-7633.S6-002

  • ADVANTAGES OF UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS:  MULTIPLE USES OF MSC'S.

  • AGING AFFECT ON STEM CELLS:

    This research study shows why our own stem cells are much less affective as we age and how our exposures weaken them.

    Aging of Cells Article

  • BACK PAIN AND SPINAL CORD INJURY:

    These studies shows umbilical cord stem cells reduce pain and improve nerve repair and they perform better than bone marrow derived stem cells.

    BACK Pain article 1

    BACK Pain article 2

  • BENEFITS OF GROWTH FACTORS:

  • BONE NECROSIS:

    This study shows MSC’s actually healed necrosis of skeletal bone. 

    BONE Healing Article

  • DEGENERATIVE DISC DISEASE:

    Mesenchymal Stem Cell therapy on degenerative discs. 

    Disc Article

  • HOST VS. GRAFT DISEASE:

    These study look at how MSC’s help reduce host rejection, even when steroids don’t work. 

    Reduce Host Rejection Article 1

    Reduce Host Rejection Article 2

  • HIP BONE LOSS & REPAIR:

    This study demonstrates UC-MSC’s ability to repair bone in the hip. 

    Hip Article

  • JUVENILE ARTHRITIS:

    This study looks at the effectiveness and safety of intravenous Umbilical MSC’s in the treatment of autoimmunity.

    Juvenile Arthritis

  • KNEE REPAIR:

    These studies looks at how stem cells heal and restore function in the knee and regenerate cartilage. 

    bjrd.pl/img/Sadlik-B-Jaroslawski-G-Gladysz-D-Puszkarz-M-Markowska-M-Pawelec-KPawelec- D-Boruczkowski-Oldak-T-2017--Knee-Cartilage-16-693.pdf

    Knee Article 1

    Knee Article 2

  • LIVER DISEASE:

    This study show’s MSC’s improve and restore function in liver disease. 

    Liver Article

  • MULTIPLE SCLEROSIS:

    These studies looks at how stem cells repair nerves damaged by M.S. and how stem cells regulate immune function to suppress M.S.

    MS Article 1

    MS Article 2

  • MYOCARDIAL INFARCTION (HEART ATTACK):

  • SHOULDER REPAIR:

    These studies look at the regenerative affects of stem cells on shoulder joint tissues. 

    Shoulder Article 1

    Shoulder Article 2

  • CARTILAGE REGENERATION IN OSTEOARTHRITIC PATIENTS, A 7 YEAR FOLLOW-UP

    This paper reports the results of the first-in-human clinical trial investigating a stem cell-based medicinal product called Cartistem (a composite of culture-expanded allogeneic human umbilical cord blood-derived mesenchymal stem cells and hyaluronic acid hydrogel). The application of the stem cell-based medicinal product showed promising efficacy in terms of durable cartilage regeneration. Clinical outcomes were improved and stable, and no significant adverse events were observed over 7 years of follow-up. There are currently no effective regenerative options for cartilage loss in osteoarthritis; thus, the researchers believe that this stem cell-based medicinal product could provide a novel therapeutic option to regenerate worn cartilage lesions in osteoarthritis. The results of this early phase clinical trial warrant further investigation with a larger number of patients

    Study and 7 Year Follow Up Article  

  • AMNIOTIC VS. BONE MARROW STEM CELLS

  • AMNIOTIC STEM CELLS POTENTIAL IN REGENERATIVE MEDICINE

  • BROCHURE FOR PLACENTAL AND AMNIOTIC CELLS (STEM SHOT-JOINTS, STEM VIVE- IV)